Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters











Database
Language
Publication year range
1.
Appl Radiat Isot ; 166: 109315, 2020 Dec.
Article in English | MEDLINE | ID: mdl-32966949

ABSTRACT

Existing and active low-energy Accelerator-Based BNCT programs worldwide will be reviewed and compared. In particular, the program in Argentina will be discussed which consists of the development of an Electro-Static-Quadrupole (ESQ) Accelerator-Based treatment facility. The facility is conceived to operate with the deuteron-induced reactions 9Be(d,n)10B and 13C(d,n)14N at 1.45 MeV deuteron energy, as neutron sources. Neutron production target development status is specified. The present status of the construction of the new accelerator development laboratory and future BNCT centre is shown.

2.
Rep Pract Oncol Radiother ; 21(2): 95-101, 2016.
Article in English | MEDLINE | ID: mdl-26933390

ABSTRACT

AIM: This work aims at giving an updated report of the worldwide status of Accelerator-Based BNCT (AB-BNCT). BACKGROUND: There is a generalized perception that the availability of accelerators installed in hospitals, as neutron sources, may be crucial for the advancement of BNCT. Accordingly, in recent years a significant effort has started to develop such machines. MATERIALS AND METHODS: A variety of possible charged-particle induced nuclear reactions and the characteristics of the resulting neutron spectra are discussed along with the worldwide activity in suitable accelerator development. RESULTS: Endothermic (7)Li(p,n)(7)Be and (9)Be(p,n)(9)B and exothermic (9)Be(d,n)(10)B are compared. In addition to having much better thermo-mechanical properties than Li, Be as a target leads to stable products. This is a significant advantage for a hospital-based facility. (9)Be(p,n)(9)B needs at least 4-5 MeV bombarding energy to have a sufficient yield, while (9)Be(d,n)(10)B can be utilized at about 1.4 MeV, implying the smallest possible accelerator. This reaction operating with a thin target can produce a sufficiently soft spectrum to be viable for AB-BNCT. The machines considered are electrostatic single ended or tandem accelerators or radiofrequency quadrupoles plus drift tube Linacs. CONCLUSIONS: (7)Li(p,n)(7)Be provides one of the best solutions for the production of epithermal neutron beams for deep-seated tumors. However, a Li-based target poses significant technological challenges. Hence, Be has been considered as an alternative target, both in combination with (p,n) and (d,n) reactions. (9)Be(d,n)(10)B at 1.4 MeV, with a thin target has been shown to be a realistic option for the treatment of deep-seated lesions.

3.
Appl Radiat Isot ; 106: 18-21, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26320739

ABSTRACT

In this work we provide some information on the present status of accelerator-based BNCT (AB-BNCT) worldwide and subsequently concentrate on the recent accelerator technology developments in Argentina.


Subject(s)
Boron Neutron Capture Therapy/instrumentation , Argentina
4.
Appl Radiat Isot ; 88: 190-4, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24332880

ABSTRACT

In the frame of accelerator-based BNCT, the (9)Be(d,n)(10)B reaction was investigated as a possible source of epithermal neutrons. In order to determine the configuration in terms of bombarding energy, target thickness and Beam Shaping Assembly (BSA) design that results in the best possible beam quality, a systematic optimization study was carried out. From this study, the optimal configuration resulted in tumor doses ≥40Gy-Eq, with a maximum value of 51Gy-Eq at a depth of about 2.7cm, in a 60min treatment. The optimal configuration was considered for the treatment planning assessment of a real Glioblastoma Multiforme case. From this, the resulted dose performances were comparable to those obtained with an optimized (7)Li(p,n)-based neutron source, under identical conditions and subjected to the same clinical protocol.


Subject(s)
Boron Neutron Capture Therapy/instrumentation , Boron/therapeutic use , Brain Neoplasms/radiotherapy , Glioblastoma/radiotherapy , Particle Accelerators/instrumentation , Radiometry/instrumentation , Radiotherapy Planning, Computer-Assisted/methods , Equipment Design , Equipment Failure Analysis , Humans , Isotopes/therapeutic use , Materials Testing , Neutrons/therapeutic use , Scattering, Radiation
5.
Appl Radiat Isot ; 88: 185-9, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24365468

ABSTRACT

The activity in accelerator development for accelerator-based BNCT (AB-BNCT) both worldwide and in Argentina is described. Projects in Russia, UK, Italy, Japan, Israel, and Argentina to develop AB-BNCT around different types of accelerators are briefly presented. In particular, the present status and recent progress of the Argentine project will be reviewed. The topics will cover: intense ion sources, accelerator tubes, transport of intense beams, beam diagnostics, the (9)Be(d,n) reaction as a possible neutron source, Beam Shaping Assemblies (BSA), a treatment room, and treatment planning in realistic cases.


Subject(s)
Boron Neutron Capture Therapy/instrumentation , Particle Accelerators/instrumentation , Radiometry/instrumentation , Equipment Design , Equipment Failure Analysis , Internationality , Technology Assessment, Biomedical
SELECTION OF CITATIONS
SEARCH DETAIL